Ultrasound-guided transcervical tubal catheterization for assisted reproduction: a learning program using laparoscopy for confirmation

Hurst, Bradley S.; Persutte, Wayne H.; Awoniyi, Caleb A.; Guadagnoli, Susie; Schlaff, William D.

doi:10.1016/s0015-0282(16)55647-7

Cited by 8 publications

(1 citation statement)

References 5 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Wurfel et al (1988) reported the first pregnancy after hysteroscopically guided transfer. Whereas pregnancy rates were poor in early reports, usually < 10% (Hazout et al, 1989;Bustillo et al, 1989;Risquez et al, 1990), more recent reports (Lucena et al, 1990;Possati et al, 1991;Ferraioloet al, 1991;Seracchioli etal., 1991;Lisseef al., 1992;Hurst et al, 1993) give an average pregnancy rate of 25%. In our study a pregnancy rate of 17.5% per cycle was achieved.…”

Section: Discussionmentioning

confidence: 99%

Surgery: ‘Blind’ transvaginal gamete intra-Fallopian transfer in distal tubal and peritubal pathology: an evaluation in respect to the laparoscopic approach

Strowitzki¹,

Korell²,

Seehaus³

et al. 1993

Human Reproduction

View full text Add to dashboard Cite

Transvaginal gamete intra-Fallopian transfer (GIFT) is a new treatment modality for patients with proven tubal patency, avoiding invasive laparoscopy. In this study 79 cycles of standard laparoscopic GIFT (group 1) were analysed in comparison to 40 cycles of transvaginal intratubal gamete transfer guided by tactile sensation (group 2). GIFT in group 1 was performed for standard indications; patients with severe intra-abdominal adhesions, distal tubal pathology, peritubal adhesions or extreme obesity were included in group 2. No difference in mean age, duration of infertility, oestradiol level and number of oocytes was found. In group 1 a clinical pregnancy rate of 33% per GIFT cycle (n = 79) was achieved. The clinical pregnancy rate in group 2 was 17.5% per gamete transfer cycle. In conclusion, transvaginal GIFT offers an acceptable chance for in-vivo fertilization to patients who cannot be treated laparoscopically despite having patent tubes and who refuse in-vitro fertilization.

show abstract

Section: Discussionmentioning

confidence: 99%